Factors associated with acute mesenteric ischemia among critically ill ventilated patients with shock : a post hoc analysis of the NUTRIREA2 trial
© 2022. Springer-Verlag GmbH Germany, part of Springer Nature..
PURPOSE: Acute mesenteric ischemia (AMI) is a rare, but life-threatening condition occurring among critically ill patients. Several factors have been associated with AMI, but the causal link is debated, most studies being retrospective. Among these factors, enteral nutrition (EN) could be associated with AMI, in particular among patients with shock. We aimed to study the factors independently associated with AMI in a post hoc analysis of the NUTRIREA-2 trial including 2410 critically ill ventilated patients with shock, randomly assigned to receive EN or parenteral nutrition (PN).
METHODS: Post hoc analysis of the NUTRIREA-2 trial was conducted. Ventilated adults with shock were randomly assigned to receive EN or PN. AMI was assessed by computed tomography, endoscopy, or laparotomy. Factors associated with AMI were studied by univariate and multivariate analysis.
RESULTS: 2410 patients from 44 French intensive care units (ICUs) were included in the study: 1202 patients in the enteral group and 1208 patients in the parenteral group. The median age was 67 [58-76] years, with 67% men, a SAPS II score of 59 [46-74], and a medical cause for ICU admission in 92.7%. AMI was diagnosed among 24 (1%) patients, mainly by computed tomography (79%) or endoscopy (38%). The mechanism of AMI was non-occlusive mesenteric ischemia (n = 12), occlusive (n = 4), and indeterminate (n = 8). The median duration between inclusion in the trial and AMI diagnosis was 4 [1-11] days. Patients with AMI were older, had a higher SAPS II score at ICU admission, had higher plasma lactate, creatinine, and ASAT concentrations and lower hemoglobin concentration, had more frequently EN, dobutamine, and CVVHDF at inclusion, developed more frequently bacteremia during ICU stay, and had higher 28-day and 90-day mortality rates compared with patients without AMI. By multivariate analysis, AMI was independently associated with EN, dobutamine use, SAPS II score ≥ 62 and hemoglobin concentration ≤ 10.9 g/dL.
CONCLUSION: Among critically ill ventilated patients with shock, EN, dobutamine use, SAPS II score ≥ 62 and hemoglobin ≤ 10.9 g/dL were independently associated with AMI. Among critically ill ventilated patients requiring vasopressors, EN should be delayed or introduced cautiously in case of low cardiac output requiring dobutamine and/or in case of multiple organ failure with high SAPS II score.
| Errataetall: |
CommentIn: Intensive Care Med. 2022 Jun;48(6):781-782. - PMID 35348818 |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:48 |
|---|---|
| Enthalten in: |
Intensive care medicine - 48(2022), 4 vom: 07. Apr., Seite 458-466 |
| Sprache: |
Englisch |
|---|
| Links: |
|---|
| Themen: |
Acute mesenteric ischemia |
|---|
| Anmerkungen: |
Date Completed 30.03.2022 Date Revised 02.08.2022 published: Print-Electronic CommentIn: Intensive Care Med. 2022 Jun;48(6):781-782. - PMID 35348818 Citation Status MEDLINE |
|---|
| doi: |
10.1007/s00134-022-06637-w |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM337226032 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM337226032 | ||
| 003 | DE-627 | ||
| 005 | 20231225233930.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s00134-022-06637-w |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1124.xml |
| 035 | |a (DE-627)NLM337226032 | ||
| 035 | |a (NLM)35190840 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Piton, Gaël |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Factors associated with acute mesenteric ischemia among critically ill ventilated patients with shock |b a post hoc analysis of the NUTRIREA2 trial |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 30.03.2022 | ||
| 500 | |a Date Revised 02.08.2022 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a CommentIn: Intensive Care Med. 2022 Jun;48(6):781-782. - PMID 35348818 | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © 2022. Springer-Verlag GmbH Germany, part of Springer Nature. | ||
| 520 | |a PURPOSE: Acute mesenteric ischemia (AMI) is a rare, but life-threatening condition occurring among critically ill patients. Several factors have been associated with AMI, but the causal link is debated, most studies being retrospective. Among these factors, enteral nutrition (EN) could be associated with AMI, in particular among patients with shock. We aimed to study the factors independently associated with AMI in a post hoc analysis of the NUTRIREA-2 trial including 2410 critically ill ventilated patients with shock, randomly assigned to receive EN or parenteral nutrition (PN) | ||
| 520 | |a METHODS: Post hoc analysis of the NUTRIREA-2 trial was conducted. Ventilated adults with shock were randomly assigned to receive EN or PN. AMI was assessed by computed tomography, endoscopy, or laparotomy. Factors associated with AMI were studied by univariate and multivariate analysis | ||
| 520 | |a RESULTS: 2410 patients from 44 French intensive care units (ICUs) were included in the study: 1202 patients in the enteral group and 1208 patients in the parenteral group. The median age was 67 [58-76] years, with 67% men, a SAPS II score of 59 [46-74], and a medical cause for ICU admission in 92.7%. AMI was diagnosed among 24 (1%) patients, mainly by computed tomography (79%) or endoscopy (38%). The mechanism of AMI was non-occlusive mesenteric ischemia (n = 12), occlusive (n = 4), and indeterminate (n = 8). The median duration between inclusion in the trial and AMI diagnosis was 4 [1-11] days. Patients with AMI were older, had a higher SAPS II score at ICU admission, had higher plasma lactate, creatinine, and ASAT concentrations and lower hemoglobin concentration, had more frequently EN, dobutamine, and CVVHDF at inclusion, developed more frequently bacteremia during ICU stay, and had higher 28-day and 90-day mortality rates compared with patients without AMI. By multivariate analysis, AMI was independently associated with EN, dobutamine use, SAPS II score ≥ 62 and hemoglobin concentration ≤ 10.9 g/dL | ||
| 520 | |a CONCLUSION: Among critically ill ventilated patients with shock, EN, dobutamine use, SAPS II score ≥ 62 and hemoglobin ≤ 10.9 g/dL were independently associated with AMI. Among critically ill ventilated patients requiring vasopressors, EN should be delayed or introduced cautiously in case of low cardiac output requiring dobutamine and/or in case of multiple organ failure with high SAPS II score | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Randomized Controlled Trial | |
| 650 | 4 | |a Acute mesenteric ischemia | |
| 650 | 4 | |a Critically ill | |
| 650 | 4 | |a Enteral nutrition | |
| 650 | 4 | |a Parenteral nutrition | |
| 650 | 4 | |a Shock | |
| 700 | 1 | |a Le Gouge, Amélie |e verfasserin |4 aut | |
| 700 | 1 | |a Boisramé-Helms, Julie |e verfasserin |4 aut | |
| 700 | 1 | |a Anguel, Nadia |e verfasserin |4 aut | |
| 700 | 1 | |a Argaud, Laurent |e verfasserin |4 aut | |
| 700 | 1 | |a Asfar, Pierre |e verfasserin |4 aut | |
| 700 | 1 | |a Botoc, Vlad |e verfasserin |4 aut | |
| 700 | 1 | |a Bretagnol, Anne |e verfasserin |4 aut | |
| 700 | 1 | |a Brisard, Laurent |e verfasserin |4 aut | |
| 700 | 1 | |a Bui, Hoang-Nam |e verfasserin |4 aut | |
| 700 | 1 | |a Canet, Emmanuel |e verfasserin |4 aut | |
| 700 | 1 | |a Chatelier, Delphine |e verfasserin |4 aut | |
| 700 | 1 | |a Chauvelot, Louis |e verfasserin |4 aut | |
| 700 | 1 | |a Darmon, Michael |e verfasserin |4 aut | |
| 700 | 1 | |a Das, Vincent |e verfasserin |4 aut | |
| 700 | 1 | |a Devaquet, Jérôme |e verfasserin |4 aut | |
| 700 | 1 | |a Djibré, Michel |e verfasserin |4 aut | |
| 700 | 1 | |a Ganster, Frédérique |e verfasserin |4 aut | |
| 700 | 1 | |a Garrouste-Orgeas, Maité |e verfasserin |4 aut | |
| 700 | 1 | |a Gaudry, Stéphane |e verfasserin |4 aut | |
| 700 | 1 | |a Gontier, Olivier |e verfasserin |4 aut | |
| 700 | 1 | |a Groyer, Samuel |e verfasserin |4 aut | |
| 700 | 1 | |a Guidet, Bertrand |e verfasserin |4 aut | |
| 700 | 1 | |a Herbrecht, Jean-Etienne |e verfasserin |4 aut | |
| 700 | 1 | |a Hourmant, Yannick |e verfasserin |4 aut | |
| 700 | 1 | |a Lacherade, Jean-Claude |e verfasserin |4 aut | |
| 700 | 1 | |a Letocart, Philippe |e verfasserin |4 aut | |
| 700 | 1 | |a Martino, Frédéric |e verfasserin |4 aut | |
| 700 | 1 | |a Maxime, Virginie |e verfasserin |4 aut | |
| 700 | 1 | |a Mercier, Emmanuelle |e verfasserin |4 aut | |
| 700 | 1 | |a Mira, Jean-Paul |e verfasserin |4 aut | |
| 700 | 1 | |a Nseir, Saad |e verfasserin |4 aut | |
| 700 | 1 | |a Quenot, Jean-Pierre |e verfasserin |4 aut | |
| 700 | 1 | |a Richecoeur, Jack |e verfasserin |4 aut | |
| 700 | 1 | |a Rigaud, Jean-Philippe |e verfasserin |4 aut | |
| 700 | 1 | |a Roux, Damien |e verfasserin |4 aut | |
| 700 | 1 | |a Schnell, David |e verfasserin |4 aut | |
| 700 | 1 | |a Schwebel, Carole |e verfasserin |4 aut | |
| 700 | 1 | |a Silva, Daniel |e verfasserin |4 aut | |
| 700 | 1 | |a Sirodot, Michel |e verfasserin |4 aut | |
| 700 | 1 | |a Souweine, Bertrand |e verfasserin |4 aut | |
| 700 | 1 | |a Thieulot-Rolin, Nathalie |e verfasserin |4 aut | |
| 700 | 1 | |a Tinturier, François |e verfasserin |4 aut | |
| 700 | 1 | |a Tirot, Patrice |e verfasserin |4 aut | |
| 700 | 1 | |a Thévenin, Didier |e verfasserin |4 aut | |
| 700 | 1 | |a Thiéry, Guillaume |e verfasserin |4 aut | |
| 700 | 1 | |a Lascarrou, Jean-Baptiste |e verfasserin |4 aut | |
| 700 | 1 | |a Reignier, Jean |e verfasserin |4 aut | |
| 700 | 0 | |a Clinical Research in Intensive Care and Sepsis (CRICS) group |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Intensive care medicine |d 1993 |g 48(2022), 4 vom: 07. Apr., Seite 458-466 |w (DE-627)NLM000234818 |x 1432-1238 |7 nnns |
| 773 | 1 | 8 | |g volume:48 |g year:2022 |g number:4 |g day:07 |g month:04 |g pages:458-466 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1007/s00134-022-06637-w |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 48 |j 2022 |e 4 |b 07 |c 04 |h 458-466 | ||